Instrument Inactif

Autres langues AIT Therapeutics Inc OTC Bulletin Board

Actions

Equipement, fournitures et distribution médicale

Autres langues

02/09	Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference
31/08	Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
31/08	Beyond Air Receives FDA Breakthrough Device Designation For LungFit GO To Treat Nontuberculous Mycobacterial Pulmonary Disease
25/08	Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments
13/08	Beyond Air, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026
13/08	Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
13/08	Qubeyond Air, Inc. Reaffirms Earnings Guidance for the for Calendar Year 2026 and for 2027
04/08	Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026
30/07	Beyond Air to Raise Up to $30.1 Million in Private Placement
30/07	Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules
26/06	Beyond Air, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
26/06	Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update
26/06	Beyond Air, Inc. Change Its Year-End from March 31 to December 31
26/06	Beyond Air, Inc. Provides Revenue Guidance for the Year Ending December 31, 2026 and Year Ending December 31, 2027
26/06	Beyond Air, Inc. Auditor Raises 'Going Concern' Doubt
22/06	Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast
10/06	Beyond Air, Inc. Urges Stockholders to Vote “FOR” All Proposals Ahead of the Upcoming Special Meeting
01/06	Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing
20/04	Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026
15/04	Beyond Air to Participate in the D. Boral Capital Global Conference 2026
02/04	Beyond Air Expands Commercial Access for LungFit PH through a Purchasing Agreement with a Top 3 National Group Purchasing Organization
01/04	Beyond Air Expands Commercial Access for LungFit® PH Through Purchasing Agreement with Top 3 National Group Purchasing Organization
01/04	Beyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO)
26/03	Beyond Air CEO Steve Lisi Resigns; COO to Succeed
26/03	Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO